Evidence-Based Dermatology

Front Cover
Hywel Williams, Michael Bigby, Thomas Diepgen, Andrew Herxheimer, Luigi Naldi, Berthold Rzany
John Wiley & Sons, Jan 22, 2009 - Medical - 744 pages
Evidence-based Dermatology, Second Edition is a unique book in the field of clinical dermatology. Written and edited by some of the world’s leading experts in evidence-based dermatology, it takes a highly evidence-based approach to the treatment of all major and many of the less common skin conditions.

The toolbox at the beginning of the book explaining how to critically appraise different studies, along with the comprehensive reviewing and appraisal of evidence in the clinical chapters makes this book distinctive in its field as do the treatment recommendations which are based on the discussion of the best available evidence using a question-driven approach and a common structure on dealing with efficacy, drawbacks and implications for clinical practice.

 

What people are saying - Write a review

User Review - Flag as inappropriate

depth-based research on long time basis on epidermis and cuticle(max nails)
ca, mg, na,O2 bases, on greens based compounds?

Contents

1 The field and its boundaries
3
2 The rationale for evidencebased dermatology
8
3 The role of the consumer and the public in evidencebased dermatology
14
4 The Cochrane Skin Group
20
II The critical appraisal
27
5 Formulating wellbuilt clinical questions
29
6 Finding the best evidence
31
7 The hierarchy of evidence
34
37 Athletes foot
358
38 Onychomycosis
362
39 Tinea capitis
386
40 Deep fungal infections
397
41 Streptococcal cellulitiserysipelas
406
42 Exanthematic reactions
418
43 Herpes simplex
428
44 Leprosy
439

8 Appraising systematic reviews and
38
9 How to critically appraise a randomized controlled trial
44
10 How to assess the evidence concerning the safety of medical interventions
52
11 What makes a good case series?
56
12 What makes a good prevalence survey?
61
13 Critical appraisal of
68
14 Applying the evidence back
73
IIIa Common inflammatory skin diseases
81
15 Acne vulgaris
83
16 Papulopustular rosacea
105
17 Perioral dermatitis
111
18 Hand eczema
117
19 Atopic eczema
128
20 Seborrheic dermatitis
164
21 Psoriasis
171
22 Lichen planus
189
23 Acute urticaria
197
24 Chronic urticaria
202
IIIb Skin cancer moles and
213
25 Primary prevention of skin cancer
215
26 Do sunscreens reduce the incidence of
226
27 Cutaneous melanoma
236
28 Squamous cell carcinoma
248
29 Basal cell carcinoma
256
30 Primary cutaneous Tcell lymphoma
272
31 Actinic keratoses and Bowens disease
294
32 Kaposis sarcoma
315
33 Photoaging
326
34 Melanocytic nevi
337
IIIc Infective skin diseases
345
35 Local treatments for cutaneous warts
347
36 Impetigo
354
45 Cutaneous leishmaniasis
451
IIId Infestations
461
46 Scabies
463
47 Head lice
471
48 Insect bites and stings
478
IIIe Disorders of pigmentation
487
49 Vitiligo
489
50 Melasma
497
IIIf Hair problems
511
51 Male and female androgenetic alopecia
513
52 Alopecia areata
518
53 Evidencebased treatment of hirsutism
527
IIIg Leg ulceration
537
54 Venous ulcers
539
IIIh Other important skin
547
55 Cutaneous lupus erythematosus
549
56 Dermatomyositis
559
57 Acquired subepidermal bullous diseases
573
58 Pemphigus
581
59 Cutaneous sarcoidosis
595
60 Erythema multiforme
608
61 StevensJohnson syndrome and toxic epidermal necrolysis
613
62 Focal hyperhidrosis
621
63 Polymorphic light eruption PLE
629
64 Infantile hemangiomas and portwine stains
633
65 Psychocutaneous disease
643
66 Pruritus
650
67 Other skin diseases for which trials exist
671
IV The future of evidencebased
701
68 Where do we go from here?
703
Index
711
Copyright

Other editions - View all

Common terms and phrases

About the author (2009)

Hywel Williams
Professor of Dermato-Epidemiology, Nottingham UK. Professor Williams is coordinating editor of the Cochrane Skin Group. He is also the dermatology adviser for Clinical Evidence (BMJ Publishing Group) which is distributed to 500 000 doctors in the US, available free to NHS institutions in the UK and is translated into 10 languages.

Michael Bigby
Assistant Professor of Dermatology, Harvard University Medical School and Chief of Dermatology, Harvard University Health Service. His chief teaching interest is in evidence-based dermatology. He edited a special issue of the Archives in Dermatology devoted to ebd, which has resulted in a quarterly ebd section to which he is a continuing contributor, and he has presented papers and chaired sessions on ebd at the AAD. He has played a major part in introducing the concept in the USA.

Thomas Diepgen
Professor of Dematology, University of Heidelberg, Gemany is a member of European Dermato-epidemiology network and a specialist in contact dermatitis, and occupationally and environmentally acquired conditions.

Andrew Herxheimer
Cochrane UK Center is a founding member of the Cochrane Collaboration and now a editor of the Consumer and Communications Group. He is part of the Consumer Network and the Adverse Effects Methods subgroup and also works with the Cochrane skin group.

Luigi Naldi
Consultant Dermatologist at Ospedale Riunit Bergamo, Italy and a member of European Dermato-epidemiology network. He specialises in psoriasis.

Berthold Rzany
C3-Professor for Evidence Based Medicine in Dermatology, Head of the division of Evidence Based Medicine at the department of dermatology at the Humboldt-University in Berlin. His research topics include aesthetic medicine, e.g. botulinum toxin A, collagen, hyaluronic acid, polyactic acid & other injectables, middle depth peelings as well as hyperhidrosis.

Bibliographic information